Market research
WHWK Whitehawk Therapeutics, Inc.
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 278M
- P/E ratio
- Not available
- Analyst target
- 7.5
- Dividend yield
- Not available
- Beta
- 0.78
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- US00032Q1040
- Market cap
- 278M
- P/E ratio
- Not available
- Analyst target
- 7.5
- Dividend yield
- Not available
- Beta
- 0.78
About
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the WHWK discussion.
No comments yet
Start a focused discussion about WHWK.